Skip to content

Clinical trials

Anxiety Disorders trials in Russia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Anxiety Disorders Country / region: Russia Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20052
20063
20071
20081
20121
20151
20171
20191
20201
20222
20232
20241
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed17
Not yet recruiting1
Recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca2
Janssen Research & Development, LLC2
Sanofi2
Valenta Pharm JSC2
Center of New Medical Technologies1
Eli Lilly and Company1
Federal State Budgetary Organization, Federal Center for Traumatology, Orthopedics and Arthroplasty1
I.M. Sechenov First Moscow State Medical University1
ITMO University1
Kalaco Scientific, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Anxiety Disorders20
Generalized Anxiety Disorder3
Adjustment Disorders2
Major Depressive Disorder2
Neurasthenia2
Attention Deficit Disorder with Hyperactivity1
Craniocerebral Trauma1
Depressive Disorder1
Irritable Bowel Syndrome1
Lymphoma, Follicular1

Trials

Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.